PT2243472T - Composição de substâncias ativas liofilizada - Google Patents

Composição de substâncias ativas liofilizada

Info

Publication number
PT2243472T
PT2243472T PT101604213T PT10160421T PT2243472T PT 2243472 T PT2243472 T PT 2243472T PT 101604213 T PT101604213 T PT 101604213T PT 10160421 T PT10160421 T PT 10160421T PT 2243472 T PT2243472 T PT 2243472T
Authority
PT
Portugal
Prior art keywords
freeze
agent compound
dried agent
dried
compound
Prior art date
Application number
PT101604213T
Other languages
English (en)
Inventor
Kuhlmann Fabian
Elsinghorst Claudia
Wagner Uwe
Malessa Dr Ralf
Original Assignee
Medskin Solutions Dr Suwelack Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medskin Solutions Dr Suwelack Ag filed Critical Medskin Solutions Dr Suwelack Ag
Publication of PT2243472T publication Critical patent/PT2243472T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT101604213T 2009-04-22 2010-04-20 Composição de substâncias ativas liofilizada PT2243472T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09158473 2009-04-22

Publications (1)

Publication Number Publication Date
PT2243472T true PT2243472T (pt) 2017-08-04

Family

ID=40941672

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101604213T PT2243472T (pt) 2009-04-22 2010-04-20 Composição de substâncias ativas liofilizada

Country Status (11)

Country Link
US (1) US9023369B2 (pt)
EP (2) EP3199147B1 (pt)
JP (1) JP6113944B2 (pt)
CN (2) CN105395469A (pt)
BR (1) BRPI1001318B8 (pt)
ES (2) ES2811307T3 (pt)
HK (1) HK1217287A1 (pt)
HR (1) HRP20171270T1 (pt)
HU (1) HUE035834T2 (pt)
PL (1) PL2243472T4 (pt)
PT (1) PT2243472T (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953716B1 (fr) * 2009-12-16 2015-03-27 Oreal Kit de formulation d'un produit cosmetique
WO2012106058A2 (en) * 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
CN107412002A (zh) 2011-06-03 2017-12-01 阿勒根公司 包括抗氧化剂的皮肤填充剂组合物
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
JP2013049671A (ja) * 2011-08-04 2013-03-14 Fancl Corp アスコルビン酸製剤
US20130199993A1 (en) * 2012-02-06 2013-08-08 Nano And Advanced Materials Institute Limited Functional chitosan scaffold with surface charge tunability as filtering medium
CN103893770B (zh) * 2012-12-26 2018-06-19 李和伟 一种冻干赋型制剂及其制备方法
US9980484B2 (en) * 2013-01-14 2018-05-29 Nano And Advanced Materials Institute Limited Chitosan based high performance filter with self-regenerating ability
CN108567745A (zh) * 2017-03-10 2018-09-25 常州柚盾实业投资有限公司 一种含有活性成分的冻干赋形制剂及其制备方法
EP3643294B1 (en) * 2017-06-19 2023-11-29 Shiseido Company, Ltd. Tablet-type freeze-dried cosmetic
CN110913829A (zh) * 2017-07-12 2020-03-24 荷兰联合利华有限公司 冷冻干燥的活性组合物及使用其的系统
US20210205202A1 (en) * 2018-07-03 2021-07-08 Conopco, Inc., D/B/A Unilever Skin care kit
CN111991342B (zh) * 2020-10-13 2023-05-09 云南舜喜再生医学工程有限公司 一种干细胞上清液冻干片及其冻干工艺
CN112957274B (zh) * 2021-02-04 2023-05-09 胶原蛋白(武汉)生物科技有限公司 一种重组胶原蛋白冻干球及制备工艺
CN112842931B (zh) * 2021-02-04 2023-05-09 胶原蛋白(武汉)生物科技有限公司 一种动物胶原蛋白冻干球、化妆品套装及制备工艺

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
DE4028622C2 (de) 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen
DE4201179A1 (de) 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
DE4328329C2 (de) 1992-08-26 1998-02-12 Suwelack Nachf Dr Otto Gefriergetrocknete Biomatrix
US5843347A (en) 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2764505B1 (fr) * 1997-06-13 1999-10-15 Alain Dogliani Nouvelles compositions cosmetiques a base de lyophilisats d'alginates alcalins et nouveaux vecteurs de penetration
US6592890B1 (en) * 1999-10-20 2003-07-15 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
AU2002230036A1 (en) 2002-02-12 2003-09-04 Ranbaxy Laboratories Limited Glucosamine-polyacrylate inter-polymer complex and applications thereof
US9023333B2 (en) 2002-10-16 2015-05-05 Stefan Frahling Method of using shaped articles to apply a scaffold-forming agent to an external skin and/or hair surface of a human or an animal
DE10248314A1 (de) 2002-10-16 2004-04-29 Dr. Suwelack Skin & Health Care Ag Verwendung von Formkörpern zur äußeren Anwendung
JP4377123B2 (ja) 2002-10-31 2009-12-02 日興製薬株式会社 皮膚外用剤組成物
DE10350654A1 (de) 2003-10-29 2005-06-02 Dr. Suwelack Skin & Health Care Ag Collagen-Träger-Wirkstoff-Zusammensetzung
AU2005209475B2 (en) 2004-01-28 2008-05-15 Unilever Plc Porous bodies and method of production thereof
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
FR2878159B1 (fr) 2004-11-24 2008-10-17 Flamel Technologies Sa Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
FR2886845B1 (fr) 2005-06-13 2009-07-03 Oreal Produit cosmetique solide
DE102006038629A1 (de) 2006-08-17 2008-02-21 Dr. Suwelack Skin & Health Care Ag Stabilisierte Wirkstoffzusammensetzung
US20100272762A1 (en) * 2009-04-22 2010-10-28 Dr. Suwelack Skin & Health Care Ag Freeze-Dried Coated Molded Article
ES2386616T3 (es) * 2009-04-22 2012-08-23 Dr. Suwelack Skin & Health Care Ag Cuerpo moldeado liofilizado que contiene ascorbilfosfato de magnesio

Also Published As

Publication number Publication date
HK1217287A1 (zh) 2017-01-06
BRPI1001318B1 (pt) 2021-02-23
JP6113944B2 (ja) 2017-04-12
HUE035834T2 (en) 2018-05-28
ES2811307T3 (es) 2021-03-11
PL2243472T3 (pl) 2017-11-30
HRP20171270T1 (hr) 2017-10-20
EP3199147A1 (de) 2017-08-02
US20100273747A1 (en) 2010-10-28
PL2243472T4 (pl) 2017-11-30
US9023369B2 (en) 2015-05-05
CN105395469A (zh) 2016-03-16
CN101919806A (zh) 2010-12-22
ES2636981T9 (es) 2018-01-02
ES2636981T3 (es) 2017-10-10
EP2243472A1 (de) 2010-10-27
EP3199147B1 (de) 2020-05-27
BRPI1001318B8 (pt) 2021-07-27
BRPI1001318A2 (pt) 2011-03-22
JP2010254690A (ja) 2010-11-11
EP2243472B1 (de) 2017-04-05

Similar Documents

Publication Publication Date Title
PL2243472T3 (pl) Związek czynnika liofilizowanego
GB0908129D0 (en) Composition
EP2423182A4 (en) DIACYLETHYLENEDIAMINE COMPOUND
GB0903759D0 (en) Compound
IL220526A0 (en) Kokumi-imparting agent
EP2478768A4 (en) ANTIPHYTOVIRAL AGENT
GB0911428D0 (en) Composition
IL220527A0 (en) Kokumi-imparting agent
GB0909362D0 (en) Composition
ZA201203414B (en) Active compound combinations
GB0914767D0 (en) Compound
GB0908642D0 (en) Composition
EP2505585A4 (en) BIS benzoxazinone CONNECTION
GB0901966D0 (en) Composition
EP2394634A4 (en) HESPERIDO-CONTAINING COMPOSITION
GB0906779D0 (en) Composition
EP2433502A4 (en) AGENT FOR REMOVING AMERTUME
GB0909213D0 (en) Compound
GB0904941D0 (en) Composition
EP2444061A4 (en) COMPOSITION CONTAINING APIGENIN
GB0911294D0 (en) Composition
GB0906548D0 (en) Composition
GB0904942D0 (en) Composition
GB0914883D0 (en) Compound
GB0903688D0 (en) Composition